ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1168

Frequently Encountered Artifacts in Novel Application of Dual-Energy CT to Vascular Imaging: A Pilot Study

Chio Yokose1, Sterling Eide 2, F. Joseph Simeone 1, Kam Shojania 3, Savvas Nicolaou 4, Fabio Becce 5 and Hyon K. Choi 1, 1Massachusetts General Hospital, Boston, MA, 2National University Hospital of Singapore, Singapore, Singapore, 3Vancouver General Hospital, Vancouver, Canada, 4Vancouver General Hospital, Vancouver, BC, Canada, 5Lausanne University Hospital, Lausanne, Switzerland

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Computed tomography (CT), gout, Sodium Urate Crystals and imaging techniques

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Imaging Of Rheumatic Diseases Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: One hypothesized link between cardiovascular disease and gout is the direct deposition of monosodium urate (MSU) crystals in atherosclerotic plaque. A 2018 ACR abstract used non-ECG-gated CT scans of the chest and neck in dual-energy mode to evaluate vascular MSU crystal deposition and reported that > 80% of patients with gout had vascular MSU deposition as well as some in healthy control patients, with no significant difference in the volume of MSU crystal deposition among gout and control patients. We reviewed 96 non-ECG gated DECT pulmonary angiograms (similar to the ACR abstract) to identify commonly encountered artifacts which could be misconstrued as true MSU deposition findings.

Methods: Consecutive patients with gout (ICD-10 code for gout and serum urate >6 mg/dL) who underwent non-ECG gated DECT pulmonary angiograms between 1/1/15 and 11/29/18 were identified using a clinical data repository. Age- and sex-matched controls were randomly chosen from a list of consecutive patients without gout who underwent the same imaging study. All images were acquired using dual-source, dual-energy CT scanners (Siemens Flash or Force DECT) and loaded into the postprocessing software (Syngo.via, Siemens, Germany) to apply an image-based two material decomposition algorithm to highlight MSU crystals in green. The images were reviewed by two radiologists experienced in interpreting DECT for MSU crystals. Presence of any green material in the vasculature was noted with its location for each patient, then further assessed with comparison to the grey-scale source images to determine if it was a true finding or artifact. Artifacts were classified into one of five categories: streak, misregistration due to motion, contrast mixing, foreign body, and noise.  Three radiologists also reviewed two cases of ECG-gated coronary DECT scans.

Results: We identified 48 gout patients and 48 age- and sex-matched controls who had undergone 51 non ECG gated PE scans. The patients were mostly men (70.8%) with mean age 67 years. The majority of DECT scans, both of cases and controls, had green material in the vasculature (85% and 84%, respectively). The most common location of green material was in the superior vena cava or right atrium (81% in cases vs. 91% in controls), followed by the aorta (27% vs 47%, respectively) and coronary arteries (40% vs 21%, respectively). However, all green material in the vasculature were ultimately attributed to artifact with the most common types of artifacts being streak (Image 1) and misregistration due to motion (Image 2). However, images from the two gout patients using ECG-gated DECT scan showed coronary MSU deposits in both the grey-scale source images as well as dual energy impages, not meeting any of artifact criteria (Image 3).

Conclusion: Non-ECG gated Vascular DECT images are susceptible to various artifacts.  Further investigation of this technology using ECG-gated CTs are warranted.


ACR 2019 DECT PE Image 1


ACR 2019 DECT PE Image 2


ACR 2019 DECT PE Image 3


Disclosure: C. Yokose, None; S. Eide, None; F. Simeone, None; K. Shojania, None; S. Nicolaou, None; F. Becce, None; H. Choi, AstraZeneca, 2, GSK, 5, Horizon, 5, Selecta, 5, Takeda, 5.

To cite this abstract in AMA style:

Yokose C, Eide S, Simeone F, Shojania K, Nicolaou S, Becce F, Choi H. Frequently Encountered Artifacts in Novel Application of Dual-Energy CT to Vascular Imaging: A Pilot Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/frequently-encountered-artifacts-in-novel-application-of-dual-energy-ct-to-vascular-imaging-a-pilot-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frequently-encountered-artifacts-in-novel-application-of-dual-energy-ct-to-vascular-imaging-a-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology